Metabolic Reprogramming and Potential Therapeutic Targets in Lymphoma.

Pang, Yuyang; Lu, Tingxun; Xu-Monette, Zijun Y; Young, Ken H

Pang, Yuyang; Lu, Tingxun; Xu-Monette, Zijun Y; Young, Ken H.

Afiliación

Pang Y; Division of Hematopathology, Department of Pathology, Duke University School of Medicine, Durham, NC 27710, USA.
Lu T; Department of Hematology, Ninth People's Hospital, Shanghai Jiao-Tong University School of Medicine, Shanghai 200025, China.
Xu-Monette ZY; Division of Hematopathology, Department of Pathology, Duke University School of Medicine, Durham, NC 27710, USA.
Young KH; Duke Cancer Institute, Durham, NC 27710, USA.

Int J Mol Sci ; 24(6)2023 Mar 13.

Article en En | MEDLINE | ID: mdl-36982568

Asunto(s)

Glucólisis; Linfoma; Humanos; Linfoma/terapia; Redes y Vías Metabólicas; Glucosa/metabolismo; Ácidos Grasos/metabolismo; Microambiente Tumoral

Palabras clave

lymphoma; metabolism; targeted therapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Glucólisis / Linfoma Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google